BioNTech SE (BNTX) Tops Q3 EPS by 236c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Wall St edges lower as chips fall; markets assess big bank earnings
- Oil prices mixed as US-Russia diesel deal hopes offset Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- CoreWeave stock drops on insider selling notice
- Sysco calls on Teamsters to end LA strike after economic deal reached
BioNTech (BNTX) PT Raised to $126 at BMO Capital
November 4, 2024 4:06 PM ESTBMO Capital analyst Etzer Darout raised the price target on BioNTech (NASDAQ: BNTX) to $126.00 (from $122.00) while maintaining a Outperform rating.
The analyst comments "BNTX announced revenues of 1.24B, above FactSet consensus (+142%) and reiterated FY24 guidance of 2.5-3.1B in revenues,... More



